Consider this – 90% patients want to self-manage their care leveraging technology
1, there are currently more than 350,000 mobile health apps available
2, and patient portals are expected to grow at an annual growth rate of 19% from 2023 to 2030
3. These numbers indicate that patients are no longer passive onlookers and have become active participants in taking control of their health. Consequently, pharma companies are looking at ways to refine their commercial models and engagement strategies to cater to these changes and deliver maximum value to the patients. As they now tread this uphill journey toward patient centricity, several aspects of
patient experience remain obscure and have caused inaccurate assumptions among global pharma organizations.